doxazosin has been researched along with amiloride in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bak, M; Christensen, S; Lomholt, N; Petersen, JS; Shalmi, M | 1 |
| Agbedana, EO; Ahaneku, JE; Salako, LA; Taylor, GO; Walker, O | 1 |
| Ahaneku, JE | 1 |
| Agbedana, EO; Ahaneku, JE; Salako, LA; Sowunmi, A; Taylor, GO; Walker, O | 1 |
| Benos, DJ; Bradford, AL; Bubien, JK; Cornwell, T; DuVall, MD; Fuller, CM | 1 |
| Brown, MJ; Caulfield, MJ; Cruickshank, JK; Ford, I; MacDonald, TM; Mackenzie, IS; McInnes, GT; Morant, SV; Padmanabhan, S; Salsbury, J; Sever, P; Webb, DJ; Williams, B | 1 |
1 review(s) available for doxazosin and amiloride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for doxazosin and amiloride
| Article | Year |
|---|---|
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Middle Aged | 1994 |
Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cross-Over Studies; Doxazosin; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 1996 |
Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Proteins; Calcium; Creatinine; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Electrolytes; Humans; Hydrochlorothiazide; Hypertension; Middle Aged | 1996 |
5 other study(ies) available for doxazosin and amiloride
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Amiloride-sensitive lithium reabsorption during doxazosin-induced blood pressure reduction in rats.
Topics: Absorption; Amiloride; Animals; Antihypertensive Agents; Doxazosin; Female; Glomerular Filtration Rate; Kidney; Lithium; Prazosin; Random Allocation; Rats; Rats, Inbred Strains; Sodium; Urination | 1991 |
Alpha-adrenergic receptors regulate human lymphocyte amiloride-sensitive sodium channels.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amiloride; Animals; Cell Transformation, Viral; Cells, Cultured; Cyclic AMP; Doxazosin; Endothelium, Vascular; Epithelial Sodium Channels; GTP-Binding Proteins; Herpesvirus 4, Human; Humans; Isoproterenol; Membrane Potentials; Norepinephrine; Patch-Clamp Techniques; Prazosin; Rats; Receptors, Adrenergic, alpha; Recombinant Proteins; Second Messenger Systems; Sodium Channels; Thionucleotides; Transcription, Genetic | 1998 |
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
Topics: Aldosterone; Amiloride; Antihypertensive Agents; Bisoprolol; Blood Pressure; Doxazosin; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Spironolactone | 2018 |